L3VLUP

CAI in the 13F filings

Caris Life Sciences Inc · CUSIP 142152107

New listing in Q2 2025· first held by a tracked manager this quarter, so its new positions are allocations rather than a turn towards it

Quarter end
30 Jun 2025
the date the book describes
Filed
27 Oct 2026
latest of these filings; the earliest 30 Jul 2025
Managers listing it
12
at least, of 95 tracked, among listed positions
Comparable managers
95
filed both Q1 2025 and Q2 2025; 0 listed it in both
Shares listed
29,320,943
combined, among listed positions
Reported value
$783m
combined, at the quarter end

Among the 95 comparable managers: 12 buyers (opened or added shares) and 0 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +29,320,943.

Managers listing CAI in Q2 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

12 of 12 holders

Largest increases and reductions, by shares

There is no earlier quarter on file to compare with.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
12 in Q2 2025 to 5 in Q2 2026

Tracked managers listing it, at least.

051015Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
CAI by quarter
QuarterHoldersReported valueBuyersSellers
Q2 202512$783m120
Q3 20259$788m54
Q4 202511$607m1715
Q1 20265$804m1219
Q2 20265$253m216

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

CAI and UNH →CAI and ELV →CAI and CI →Choose a stock to compare with CAI →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own CAI, latest filings →Back to the 13F Explorer →